Abstract
Both the ductus arteriosus and foramen ovale provide a means whereby blood flow in the fetus is diverted away from the high-resistance pulmonary vascular bed to the much lower resistance systemic circulation. At birth or soon thereafter the pulmonary vascular bed experiences a substantial degree of vasodilation and lowering of vascular resistance by mechanisms presently unknown, whereas systemic vascular resistance increases. The former occurs in order to permit the dramatic rise in pulmonary artery blood flow that is necessary for initiation of lung function and thus the exchange of respiratory gases, to replace the function of the placenta. In concert with these changes in lung function and pulmonary blood flow is the anatomic closure of the foramen ovale and the functional closure of the ductus arteriosus. However, in contrast to the foramen ovale, the ductus arteriosus generally remains patent for some time after birth. Whereas this patency is of little consequence to the well term infant [1], it may result in substantial problems in the preterm infant due to the magnitude of the left-to-right shunt that may occur. This chapter discusses the patent ductus arteriosus (PDA) in the preterm infant, pointing out present-day problems in our understanding of its role in neonatal illness and thus in the care and treatment of the preterm infant, in particular the infant of less than 1,500 g birth weight.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gentile R, Stevenson G, Dooley T, et al: Pulsed doppler echocardiographie determination of time of ductal closure in normal newborn infants. J Pediatr 98:443–448, 1981.
Edmonds LH, Gregory GA, Heymann MA, et al: Surgical closure of the ductus arteriosus in premature infants. Circulation 58:856–863, 1973.
Siassi B, Blanco C, Cabal LA, et al: Incidence and clinical features of patent ductus arteriosus in low-birth-weight infants: A prospective analysis of 150 consecutively born infants. Pediatrics 57:347–351, 1976.
Cotton RB, Stahlman MT, Kovar I, et al: Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 92:467–473, 1978.
Kitterman JA, Edmunds LH, Gregory GA, et al: Patent ductus arteriosus in premature infants: Incidence, relation to pulmonary disease and management. N Engl J Med 287:473–477, 1972.
Cotton RB, Stahlman MT, Bender HW, et al: Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 93:647–651, 1978.
Naulty GM, Horn S, Conry J, et al: Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. J Pediatr 93:682–684, 1978.
Cotton RB, Lindstrom DP, Stahlman MT: Early prediction of symptomatic patent ductus arteriosus from perinatal risk factors: A discriminant analysis model. Acta Pediatr Scand 70:723–727, 1981.
Stevenson JG: Fluid administration in the association of patent ductus arteriosus complicating respiratory distress syndrome. J Pediatr 90:257–261, 1977.
Bell EF, Warburton D, Stonestreet BS, et al: Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive failure in premature infants. N Engl J Med 302:598–604, 1980.
Furzan JA, Reisch J, Tyson JE, et al: Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants. Early Hum Devel 12:39–48, 1985.
Bucci G, Scalamandre A, Savignoni PC, et al: The systemic systolic blood pressure of newborns with low weight: A multiple regression analysis. Acta Pediatr Scand (Suppl) 229:1–26, 1972.
Arant BS Jr: Nonrenal factors influencing renal function during the perinatal period. Clin Perinatol 8:255–240, 1981.
Lorenz JM, Kleinman LI, Kotagal UR, et al: Water balance in very low-birth-weight infants: Relationship to water and sodium intake and effect on outcome. J Pediatr 101:423–432, 1982.
Relier MD, Lorenz JM, Kotagal UR, et al: Hemodynamically significant PDA: An echocardiographie and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance. Pediatr Cardiol 6:17–24, 1985.
Mahony L, Carnero V, Brett C, et al: Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birthweight infants. N Engl J Med 306:506–510, 1982.
Jacob J, Gluck L, DiSessa T, et al: The contribution of PDA in the neonate with severe RDS. J Pediatr 96:79–87, 1980.
Mahony L, Caldwell RL, Girod DA, et al: Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr 106:801–805, 1985.
Dudell GG, Gersony WM: Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 104:915–920, 1984.
Ellison RC, Peckham GJ, Lang P, et al: Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 71:364–372, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Rosenfeld, C.R. (1989). Hemodynamically Significant Patent Ductus Arteriosus in Low-Birth-Weight Infants: Fact or Fiction?. In: Rathi, M. (eds) Current Perinatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-8794-7_18
Download citation
DOI: https://doi.org/10.1007/978-1-4613-8794-7_18
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-8796-1
Online ISBN: 978-1-4613-8794-7
eBook Packages: Springer Book Archive